198 related articles for article (PubMed ID: 14975242)
21. Simultaneous, bidirectional inhibitory crosstalk between PPAR and STAT5b.
Shipley JM; Waxman DJ
Toxicol Appl Pharmacol; 2004 Sep; 199(3):275-84. PubMed ID: 15364543
[TBL] [Abstract][Full Text] [Related]
22. Nuclear receptors as negative modulators of STAT3 in multiple myeloma.
Wang LH; Yang XY; Zhang X; Farrar WL
Cell Cycle; 2005 Feb; 4(2):242-5. PubMed ID: 15655377
[TBL] [Abstract][Full Text] [Related]
23. PPAR activators inhibit endothelial cell migration by targeting Akt.
Goetze S; Eilers F; Bungenstock A; Kintscher U; Stawowy P; Blaschke F; Graf K; Law RE; Fleck E; Gräfe M
Biochem Biophys Res Commun; 2002 May; 293(5):1431-7. PubMed ID: 12054675
[TBL] [Abstract][Full Text] [Related]
24. 15-Deoxy-delta12,14-PGJ2 inhibits IL-6-induced Stat3 phosphorylation in lymphocytes.
Kim HJ; Rho YH; Choi SJ; Lee YH; Cheon H; Um JW; Sohn J; Song GG; Ji JD
Exp Mol Med; 2005 Jun; 37(3):179-85. PubMed ID: 16000871
[TBL] [Abstract][Full Text] [Related]
25. Proline oxidase, a proapoptotic gene, is induced by troglitazone: evidence for both peroxisome proliferator-activated receptor gamma-dependent and -independent mechanisms.
Pandhare J; Cooper SK; Phang JM
J Biol Chem; 2006 Jan; 281(4):2044-52. PubMed ID: 16303758
[TBL] [Abstract][Full Text] [Related]
26. Peroxisome proliferator-activated receptor (PPAR)-gamma expression in human vascular smooth muscle cells: inhibition of growth, migration, and c-fos expression by the peroxisome proliferator-activated receptor (PPAR)-gamma activator troglitazone.
Benson S; Wu J; Padmanabhan S; Kurtz TW; Pershadsingh HA
Am J Hypertens; 2000 Jan; 13(1 Pt 1):74-82. PubMed ID: 10678274
[TBL] [Abstract][Full Text] [Related]
27. Peroxisome proliferator-activated receptor gamma activation modulates cyclin D1 transcription via beta-catenin-independent and cAMP-response element-binding protein-dependent pathways in mouse hepatocytes.
Sharma C; Pradeep A; Pestell RG; Rana B
J Biol Chem; 2004 Apr; 279(17):16927-38. PubMed ID: 14764597
[TBL] [Abstract][Full Text] [Related]
28. Neuroprotective effects of PPARgamma agonists against oxidative insults in HT-22 cells.
Aoun P; Watson DG; Simpkins JW
Eur J Pharmacol; 2003 Jul; 472(1-2):65-71. PubMed ID: 12860474
[TBL] [Abstract][Full Text] [Related]
29. Inhibition of IL-10-induced STAT3 activation by 15-deoxy-Delta12,14-prostaglandin J2.
Ji JD; Kim HJ; Rho YH; Choi SJ; Lee YH; Cheon HJ; Sohn J; Song GG
Rheumatology (Oxford); 2005 Aug; 44(8):983-8. PubMed ID: 15840591
[TBL] [Abstract][Full Text] [Related]
30. Vascular inflammation is negatively autoregulated by interaction between CCAAT/enhancer-binding protein-delta and peroxisome proliferator-activated receptor-gamma.
Takata Y; Kitami Y; Yang ZH; Nakamura M; Okura T; Hiwada K
Circ Res; 2002 Sep; 91(5):427-33. PubMed ID: 12215492
[TBL] [Abstract][Full Text] [Related]
31. Interferon regulatory factor-1 mediates PPARgamma-induced apoptosis in vascular smooth muscle cells.
Lin Y; Zhu X; McLntee FL; Xiao H; Zhang J; Fu M; Chen YE
Arterioscler Thromb Vasc Biol; 2004 Feb; 24(2):257-63. PubMed ID: 14656743
[TBL] [Abstract][Full Text] [Related]
32. Expression of peroxisome proliferator-activated receptor gamma (PPARgamma) in human transitional bladder cancer and its role in inducing cell death.
Guan YF; Zhang YH; Breyer RM; Davis L; Breyer MD
Neoplasia; 1999 Oct; 1(4):330-9. PubMed ID: 10935488
[TBL] [Abstract][Full Text] [Related]
33. Up-regulation of p21 gene expression by peroxisome proliferator-activated receptor gamma in human lung carcinoma cells.
Han S; Sidell N; Fisher PB; Roman J
Clin Cancer Res; 2004 Mar; 10(6):1911-9. PubMed ID: 15041706
[TBL] [Abstract][Full Text] [Related]
34. Peroxisome proliferator-activated receptor gamma inhibits expression of minichromosome maintenance proteins in vascular smooth muscle cells.
Bruemmer D; Yin F; Liu J; Berger JP; Kiyono T; Chen J; Fleck E; Van Herle AJ; Forman BM; Law RE
Mol Endocrinol; 2003 Jun; 17(6):1005-18. PubMed ID: 12677008
[TBL] [Abstract][Full Text] [Related]
35. PPARalpha activation by Wy 14643 induces transactivation of the rat UCP-1 promoter without increasing UCP-1 mRNA levels and attenuates PPARgamma-mediated increases in UCP-1 mRNA levels induced by rosiglitazone in fetal rat brown adipocytes.
Teruel T; Clapham JC; Smith SA
Biochem Biophys Res Commun; 1999 Oct; 264(2):311-5. PubMed ID: 10529360
[TBL] [Abstract][Full Text] [Related]
36. Inhibition of adhesive interaction between multiple myeloma and bone marrow stromal cells by PPARgamma cross talk with NF-kappaB and C/EBP.
Wang LH; Yang XY; Zhang X; Farrar WL
Blood; 2007 Dec; 110(13):4373-84. PubMed ID: 17785586
[TBL] [Abstract][Full Text] [Related]
37. Peroxisome proliferator-activated receptor-gamma agonists modulate macrophage activation by gram-negative and gram-positive bacterial stimuli.
Guyton K; Zingarelli B; Ashton S; Teti G; Tempel G; Reilly C; Gilkeson G; Halushka P; Cook J
Shock; 2003 Jul; 20(1):56-62. PubMed ID: 12813370
[TBL] [Abstract][Full Text] [Related]
38. Induction of differentiation and peroxisome proliferator-activated receptor gamma expression in colon cancer cell lines by troglitazone.
Kato M; Kusumi T; Tsuchida S; Tanaka M; Sasaki M; Kudo H
J Cancer Res Clin Oncol; 2004 Feb; 130(2):73-9. PubMed ID: 14634802
[TBL] [Abstract][Full Text] [Related]
39. Expression of PPARgamma in eosinophils and its functional role in survival and chemotaxis.
Ueki S; Adachi T; Bourdeaux J; Oyamada H; Yamada Y; Hamada K; Kanda A; Kayaba H; Chihara J
Immunol Lett; 2003 Apr; 86(2):183-9. PubMed ID: 12644321
[TBL] [Abstract][Full Text] [Related]
40. Effects of peroxisome proliferator-activated receptor agonists on LPS-induced neuronal death in mixed cortical neurons: associated with iNOS and COX-2.
Kim EJ; Kwon KJ; Park JY; Lee SH; Moon CH; Baik EJ
Brain Res; 2002 Jun; 941(1-2):1-10. PubMed ID: 12031542
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
